Sutro Biopharma, Inc. ( STRO) - Key Metrics
STRO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.36 | -$5.45 | -$3.08 | -$3.10 |
| 2025Q3 | $1.14 | -$6.70 | -$4.50 | -$4.53 |
| 2025Q2 | $7.54 | -$1.36 | -$5.29 | -$5.30 |
| 2025Q1 | $2.09 | -$9.14 | -$8.17 | -$8.31 |
STRO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -0.53 |
| 2025Q3 | ? | -0.32 |
| 2025Q2 | ? | -1.31 |
| 2025Q1 | ? | -0.18 |
STRO
Price: $28.17
52 week price:
Earnings Per Share: -16.35 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 223541
Market Capitalization: 249.6 million